美股新聞 標題聯播 · 近 24 小時 336 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · UTHR近 30 天 17 則 · 第 1 / 1 頁
- Biotech Options Buzz: UTHR, NMRA, EWTX
- LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
- Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?
- United Therapeutics (UTHR) Sets $477.6 Million Buyback. Can Pipeline Funding Keep Pace?
- Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio?
- Therapeutics Stocks Q2 Teardown: United Therapeutics (NASDAQ:UTHR) Vs The Rest
- United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization
- Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
- United Therapeutics (UTHR) Down 8% Since Last Earnings Report: Can It Rebound?
- FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
- United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis
- Anheuser-Busch plant in Merrimack sold to United Therapeutics for $47.5M
- Top Research Reports for Toyota Motor, CrowdStrike & Welltower
- United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
- Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition?
- FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH
- United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。